Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aerosolized Pulmozyme for severe respiratory failure in COVID-19
2020-001849-39Phase 2Completed
- Sponsor
- Region Skåne
- Start
- Apr 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial in coronavirus disease 2019 (COVID-19) comparing Pulmozyme with Placebo (2 arms). Started Apr 2020; status: completed.
02
Drugs
dornase alfa
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001849-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001849-39.